Skip to main content
OpenTrials

Clinical trial condition

Muscular Dystrophy, Duchenne

Explore clinical trials studying Muscular Dystrophy, Duchenne. Study availability and eligibility vary by location and protocol.

358 public trials 57 recruiting studies
Refine in advanced search Browse all conditions

Muscular Dystrophy, Duchenne trial results

Completed

Study of Ataluren in ≥2 to <5 Year-Old Male Participants With Duchenne Muscular Dystrophy

NCT02819557

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Child Neuro NWF Gulf Breeze, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Children's Hospital Boston Boston, Massachusetts, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Completed

Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)

NCT01826487

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Genetic Diseases, X-Linked, +7 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • UC Davis Medical Center Sacramento, California, United States
  • Children's Hospital Colorado - Center for Cancer and Blood Disorders Aurora, Colorado, United States
  • Child Neurology Center of Northwest Florida Gulf Breeze, Florida, United States
View all 55 locations
View Trial Details
Completed

A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy

NCT02752048

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Nagoya City University Hospital Aichi, Japan
  • National Hospital Organization Nagara Medical Center Gifu, Japan
  • Kobe University Hospital Hyōgo, Japan
  • National Hospital Organization Utano Hospital Kyoto, Japan
View Trial Details
Completed

Phase 2B Study of PTC124 (Ataluren) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)

NCT00592553

Conditions
Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, +9 more
Locations
  • University of California-Davis Sacramento, California, United States
  • The Children's Hospital Aurora, Colorado, United States
  • Child Neurology Center of Pensacola Pensacola, Florida, United States
  • University of Iowa Healthcare Iowa City, Iowa, United States
View all 37 locations
View Trial Details
Completed

Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy

NCT02286947

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Genetic Diseases, X-Linked, +7 more
Locations
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • University of California, Davis Medical Center Sacramento, California, United States
  • University of Iowa Children's Hospital Iowa City, Iowa, United States
  • Kennedy Krieger Institute Baltimore, Maryland, United States
View Trial Details
Completed

Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy

NCT01540409

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy (DMD), Genetic Diseases, Inborn, +8 more
Locations
  • Miller Children's Hospital Long Beach, California, United States
  • University of Florida Clinical Research Center Gainesville, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions